Navigation Links
Transcend Medical Raises $35 Million Series B Round Towards Development of Novel Glaucoma Treatment
Date:6/22/2009

MENLO PARK, Calif., June 22 /PRNewswire/ -- Transcend Medical, Inc., an ophthalmic device company dedicated to delivering breakthrough advances in the treatment of glaucoma, announced today that it has closed a $35 million Series B round and is continuing the rapid development of its Transcend CyPass(TM) System, a novel proprietary system for the minimally-invasive treatment of glaucoma.

Lead investor HLM Venture Partners, along with other new investors Canaan Partners, Technology Partners and Latterell Venture Partners made significant contributions to this round of financing, which was also strongly supported by current investors Morgenthaler Ventures and Split Rock Partners.

"Completing this round is a testament to the progress of our technology and a strong validation of its potential to impact the future of glaucoma treatment," said Brian Walsh, President and Chief Executive Officer of Transcend Medical. "We are now well-capitalized to accomplish all initial clinical and commercial milestones for the company."

The Transcend CyPass System is being developed to both replace current glaucoma therapies, which either lack effectiveness or are very invasive, and to expand treatment to a much larger patient population. Transcend Medical is focused on a less invasive procedure using a novel, proprietary system that reduces intraocular pressure (IOP).

"There is a significant need to improve how we treat glaucoma," commented Eugene de Juan, Jr., M.D., Jean Kelly Stock Distinguished Professor of Ophthalmology at UCSF and Founder of Transcend Medical. "Today's treatment options for glaucoma are highly limited and only feasible in a limited portion of those affected by the disease worldwide."

"We are encouraged by the CyPass System's minimally invasive delivery which is of significant benefit to patients, provides important ease of use features for physicians, and could result in ear
'/>"/>

SOURCE Transcend Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Life Extension Book, TRANSCEND, Hits Bookstores Today
2. Transcending politics to save lives
3. Transcendental Meditation buffers students against college stress: Study
4. Transcend Medical Announces New President and CEO and Appointment of Chairman of the Board
5. Transcendental meditation effective in reducing high blood pressure, study shows
6. Patients of Courage Transcend Physical Disfigurement, Help Others
7. Physician Dissatisfaction Leads to New Medical Conference
8. Galil Medical Ltd. Sues HealthTronics for Interfering with the Galil/Endocare Merger Agreement
9. CelebrityDiagnosis.com Presents Famous Patients As Medical Lessons
10. Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation
11. U.S. Army Increases Medical and Dental School Benefits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
(Date:12/5/2009)Midbrook,s advanced Technology Center helps companies develop and test their cleaning processes. The technology available to the lab allows it to work in a variety of industries and solve problems for
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2
...he misuse of ambulances of government hospitals by...g that their services be availed of only by patie...r and Justice S.N. Agrawal said: "No ambulance of ...on a petition, the bench said all vehicles fitted ...
...rnor, James E. McGreevy appears to be knocking on ...n the news for the right reasons. He has been wel...lian. Former Gov. James E. McGreevy, who wa...ly undergoing the church's "discernment" phase, wh...
... when her pictures appeared in magazine articles a... all that blew up, I felt terrible. It appeared th... not. I am thin because that's what I am, and I wa...nightley had just finished filming "Pirates of the...
...tes (UAE) said the government is working to draft ...he country's prevention programme of genetic diso...on the mother or child's health. But the choice to...e ministry of health was quoted as saying in Gulf ...
...onfirmed that the malfunction of a gene causes sch...ublished Thursday's issue of the journal Neuron. ...offer a possible animal model for developing treat...e researchers sought to explore the consequences o...
...aine headaches are more than twice as likely to al...ion or anxiety than soldiers who do not have migr...olved 3,621 United States Army soldiers who were g...cent, completed the questionnaire. Of those, 19 pe...
Other Medicine News:Health News:Malfunction of Gene Causes Schizophrenia, Depression 2Health News:Migraines may Be a Symptom of Other Problems for Iraq Soldiers 2
(Date:12/4/2009)WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: AZN ) today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tab
(Date:12/3/2009)NEW YORK, Dec. 3 Guidepoint Global, LLC , a leading primary research firm, today announced the launch of their Sleep Apnea Tracker, a monthly longitudinal data release that monitors and projects tre
(Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,
Breaking Medicine Technology:US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Texas Institute for Surgery at Presbyterian Hospital of Dallas Introduces the First Wireless OR in DFW 49253 1Texas Institute for Surgery at Presbyterian Hospital of Dallas Introduces the First Wireless OR in DFW 49253 234 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 134 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 234 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 334 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 4Michael E DeBakey Journalism Award Recipients Announced 49243 1
..., March 10 BioSpecifics Technologies Corp. (Nasda...g first in class collagenase-based products, today...n, will present a corporate overview at the upcomi...rence on Tuesday, March 17, 2009, at 9:30am ET at ...live webcast of the presentation can be accessed a...
...raClip(R) System Continues to Expand in the Europe..., Inc., the leader in the development of devices f...unced today that the first series of patients have...ystem at the Cardiocentro Ticino in Lugano, Switze... device commercially available in the European Uni...
Other Medicine Technology:First Swiss Patients Treated with the Percutaneous MitraClip(R) System 2First Swiss Patients Treated with the Percutaneous MitraClip(R) System 3
Shandon Histobath 2
Liquichek Blood Gas Plus CO-Oximeter Control (IL)
Liquichek CK/LD Isoenzyme Control
Lyphochek Diabetes Control
Medicine Products: